What is Proton Intelligence?
Proton Intelligence is at the forefront of transforming hyperkalemia management, particularly for individuals battling chronic kidney disease (CKD) and heart failure. The company is developing a groundbreaking, real-time, on-demand potassium monitoring wearable device. This innovation is designed to empower clinicians with precise tools for safely treating patients at risk of hyperkalemia, a condition affecting over 3.7 million Americans. By filling a critical gap in current monitoring capabilities, Proton Intelligence targets healthcare providers and patients requiring diligent potassium level oversight.
How much funding has Proton Intelligence raised?
Proton Intelligence has raised a total of $7M across 1 funding round:
Angel/Seed
$7M
Angel/Seed (2024): $7M with participation from 15th Rock Ventures, SOSV, Tenmile, EXOR, and We Venture
Key Investors in Proton Intelligence
15th Rock Ventures
15th Rock Ventures is a venture capital firm focused on enhancing human capabilities through technology, particularly in robotics and AI, with an eye towards international market expansion.
SOSV
SOSV is a multi-stage venture capital investor that provides both intellectual and financial capital to accelerate the growth of innovative founders and their ideas.
Tenmile
Tenmile is an investment firm dedicated to improving human health by backing innovative companies that address significant unmet medical needs, aiming to foster global health innovation.
What's next for Proton Intelligence?
With this major enterprise-level funding, Proton Intelligence is poised for significant expansion and product development. The strategic investment will likely accelerate the refinement of their continuous potassium monitoring wearable, aiming to bring this vital diagnostic tool to market. Future efforts will focus on scaling manufacturing, expanding clinical trials, and forging partnerships within the healthcare ecosystem to ensure widespread adoption. The company's trajectory suggests a strong emphasis on clinical validation and market penetration to establish its solution as the standard of care for hyperkalemia monitoring.
See full Proton Intelligence company page
